SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 65 filers reported holding SUTRO BIOPHARMA INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $1,482,000 | -70.2% | 79,700 | -63.6% | 0.02% | -72.6% |
| Q1 2021 | $4,980,000 | -12.0% | 218,800 | -16.0% | 0.07% | -19.8% |
| Q4 2020 | $5,658,000 | +758.6% | 260,600 | +297.6% | 0.09% | +550.0% |
| Q3 2020 | $659,000 | +29.5% | 65,542 | 0.0% | 0.01% | +16.7% |
| Q2 2020 | $509,000 | -82.8% | 65,542 | -77.3% | 0.01% | -87.9% |
| Q1 2020 | $2,951,000 | -4.5% | 289,306 | +3.0% | 0.10% | +20.7% |
| Q4 2019 | $3,090,000 | +21.6% | 280,934 | +0.5% | 0.08% | -1.2% |
| Q3 2019 | $2,541,000 | -18.5% | 279,577 | +2.1% | 0.08% | -15.3% |
| Q2 2019 | $3,117,000 | +13.6% | 273,906 | +13.6% | 0.10% | -4.9% |
| Q1 2019 | $2,745,000 | -7.8% | 241,027 | -27.0% | 0.10% | -18.9% |
| Q4 2018 | $2,978,000 | -44.6% | 330,210 | -7.8% | 0.13% | -23.0% |
| Q3 2018 | $5,374,000 | – | 358,278 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $34,466,000 | 16.86% |
| Samsara BioCapital, LLC | 1,675,579 | $31,652,000 | 4.97% |
| First Light Asset Management, LLC | 2,191,439 | $41,396,000 | 2.73% |
| FRAZIER MANAGEMENT LLC | 1,468,663 | $27,743,000 | 2.22% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,306,000 | 2.13% |
| Opaleye Management Inc. | 537,800 | $10,159,000 | 1.90% |
| Parkman Healthcare Partners LLC | 163,389 | $3,086,000 | 0.78% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,233,695 | $42,194,000 | 0.71% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 139,331 | $2,629,000 | 0.63% |
| BVF INC/IL | 826,825 | $15,619,000 | 0.61% |